Trials / Active Not Recruiting
Active Not RecruitingNCT05116293
Effect of Testosterone Treatment on Drug Metabolism and Transport
Effect of Gender-Affirming Testosterone Therapy on Drug Metabolism, Transport, and Gut Microbiota
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (estimated)
- Sponsor
- University of Washington · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This project will evaluate the effect of gender-affirming testosterone treatment on how other medications are processed by the body.
Detailed description
Gender-affirming hormone therapy may include testosterone, a hormone that the body creates and uses naturally. Testosterone is prepared as a medication that patients may take to increase hormone levels. Changes in testosterone concentrations in the body may affect how the body processes other medicines. The purpose of this study is to find out how testosterone therapy affects a single tracer dose of approved medicines in the blood (midazolam, digoxin, and acetaminophen) and to confirm testosterone treatment does not affect natural bacterial in the gut.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Midazolam oral solution | Oral syrup |
| DRUG | Digoxin Oral Tablet | Oral tablet |
| DRUG | Acetaminophen Oral Tablet | Oral tablet |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2024-02-15
- Completion
- 2025-12-31
- First posted
- 2021-11-11
- Last updated
- 2025-06-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05116293. Inclusion in this directory is not an endorsement.